Showing 1951-1960 of 20420 results for "".
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
https://reachmd.com/programs/project-oncology/the-potential-impact-of-rcc-molecular-subtypes-on-treatment-outcomes/26533/Tune in to hear expert insights on recent research investigating if renal cell carcinoma molecular subtypes impact treatment outcomes.Interpreting Perioperative Trial Designs in Resectable NSCLC Research
https://reachmd.com/programs/project-oncology/perioperative-trial-designs-resectable-nsclc/49114/As perioperative treatment strategies rapidly evolve in resectable non-small cell lung cancer (NSCLC), understanding how to interpret clinical trial designs has become increasingly critical for oncology care teams. That’s why Dr. Charles Turck speaks with Drs. Laura Alder and Christine Bestvina abouInvestigating the Latest Innovations in IBD
https://reachmd.com/programs/gi-insights/investigating-the-latest-innovations-in-ibd/13471/From new diagnostic tools to novel therapies, find out how IBD care and management have evolved.Spontaneous Intracranial Hemorrhage Secondary to Rare Pial Arteriovenous Fistula Rupture
https://reachmd.com/diseases-diagnoses/stroke/spontaneous-intracranial-hemorrhage-secondary-to-rare-pial-arteriovenous-fistula-rupture/35445/Pial arteriovenous fistulas are rare cerebrovascular malformations most commonly seen in children; however, they can be found in adults, especially in the setting of an intracranial hemorrhage.Genetic Testing Among Women with Breast Cancer Increasing, Can Impact Treatment Decisions
https://reachmd.com/programs/the-jama-report/genetic-testing-among-women-breast-cancer-increasing-can-impact-treatment-decisions/7935/[Read the Article] Rates of genetic testing for BRCA1 and BRCA2 mutations have increased among younger women diagnosed with breast cancer, according to a new study. The study focused on nearly 900 women diagnosed with breast cancer at age 40 or younger. Researchers looked at rates of genetic testingExtra Innings – Sustaining Victory Beyond the First Game
https://reachmd.com/programs/cme/extra-innings-sustaining-victory-beyond-the-first-game/56439/Step up to the plate with evidence-based strategies to identify patients with high-risk ASCVD, optimize LDL-C, and up your game in secondary prevention.Improving Adherence to Topical Regimens
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/improving-adherence-to-topical-regimens/48780/Zoe Diana Draelos, MD, discusses strategies for improving adherence to topical regimens in chronic atopic dermatitis.Advancing Precision Medicine in NSCLC: Real-World Impact of the PREDICT Initiative
https://reachmd.com/programs/project-oncology/advancing-precision-medicine-in-nsclc-real-world-impact-of-the-predict-initiative/39034/A 2025 study in Chest evaluated PREDICT, a precision medicine program at a large academic-community practice, designed to streamline testing and expand access to personalized treatment for non-small cell lung cancer (NSCLC). Hear from ReachMD's Ryan Quigley as he shares the key impacts of this approEvaluating High- vs. Low-Dose Corticosteroids in Acute IPF Exacerbations
https://reachmd.com/programs/clinicians-roundtable/evaluating-high-vs-low-dose-corticosteroids-in-acute-ipf-exacerbations/35655/A recent study investigated whether pulse-dose corticosteroids offer a benefit over lower doses in managing acute exacerbations of idiopathic pulmonary fibrosis (IPF). Join Dr. Divya Shankar as she explains the real-world data, variability in prescribing patterns, and outcomes observed in differentAnti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
https://reachmd.com/programs/medical-industry-feature/anti-amyloid-therapy-early-alzheimers-real-world/48941/Explore the clinical use of the anti-amyloid therapy LEQEMBI® (lecanemab-irmb) for early Alzheimer’s disease in this four-part, on-demand video series. The program offers expert-led guidance on patient selection and monitoring, 4-year efficacy and safety data, and emerging real-world evidence. Featu